Acerus Announces Participation in HC Wainwright Conference
23 August 2021 - 01:30PM
Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”)
(TSX:ASP; OTCQB:ASPCF) today announced that it will participate in
the H.C. Wainwright 23rd Annual Global Investment Conference to be
held September 13-15 in New York. Management will host a general
presentation, viewable online, and be available for virtual
meetings with institutional investors throughout the course of the
conference.
Additional information will be posted on the
Company’s website when available, including a copy of the
presentation material and webcast link. Institutional investors are
welcome to contact the conference hosts to arrange one-on-one calls
with management.
About Acerus Acerus
Pharmaceuticals Corporation is a Canadian-based specialty
pharmaceutical company focused on the commercialization and
development of innovative prescription products that improve
patient experience, with a primary focus in the field of men’s
health. The Company commercializes its products via its own
salesforce in the United States and Canada, and through a global
network of licensed distributors in other territories.
Acerus’ shares trade on TSX under the symbol ASP
and on the OTCQB under the symbol ASPCF. For more information,
visit www.aceruspharma.com and follow us on Twitter and
LinkedIn.
Contacts: Company
Contactir@aceruspharma.com
Chris WittyAcerus Investor Relations(646)
438-9385cwitty@darrowir.com
Acerus Pharmaceuticals (TSX:ASP)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Acerus Pharmaceuticals (TSX:ASP)
Historical Stock Chart
Von Mär 2023 bis Mär 2024